Joshua M. Stolker, MD
NPI 1447292875ActiveIndividual· Internal Medicine, Interventional Cardiology· Washington, MO
Internal Medicine, Interventional Cardiology (MD) in Washington, Missouri, trained at Duke University School of Medicine (class of 1998). Their prescriptions cost Medicare Part D more than their services did: $1,247,196 for 6,064 claims, against $95,197 paid for services in 2024. Novo Nordisk Inc was the largest of 16 companies reporting payments in 2025, $124,414 in all, mostly speaking and faculty fees.
Overview
| NPI | 1447292875 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jun 11, 2006 |
| Last updated in NPPES | Sep 28, 2025 |
| Certified by provider | Sep 28, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Interventional Cardiology Primary | 207RI0011X | 2001024953 | MO |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 2001024953 | MO |
| Internal Medicine, Interventional Cardiology | 207RI0011X | 46487 | OK |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Interventional Cardiology (IA); Practitioner - Cardiovascular Disease (Cardiology) (MO); Practitioner - Interventional Cardiology (OK) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 750 |
|---|---|
| Services billed | 1,353 across 73 procedure codes |
| Paid by Medicare | $95,197 |
Part D prescriptions in 2024
| Prescriptions (claims) | 6,064 · 15,408 30-day fills |
|---|---|
| Patients | 768 |
| Total drug cost | $1,247,196 |
| Generic share | 81% of claims |
Education and affiliations
| Medical school | Duke University School of Medicine |
|---|---|
| Graduation year | 1998 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
| Secondary specialties | Interventional Cardiology |
Medical group
- Mercy Clinic Heart and Vascular LLCSaint Louis, MO · 113 clinicians
Hospital affiliations
- Mercy Hospital LebanonLebanon, MO
- Mercy Hospital SouthSaint Louis, MO
- Mercy Hospital St LouisSaint Louis, MO
- Mercy Hospital WashingtonWashington, MO
- St Lukes HospitalChesterfield, MO
Industry payments (Open Payments)
- 2025$124,414 · 116 payments from 16 companies
- 2024$106,026 · 145 payments from 21 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $76,960 | 38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33,060 | 28 |
| Lilly USA, LLC | $8,360 | 5 |
| Amgen Inc. | $1,594 | 8 |
| Penumbra, Inc. | $1,593 | 9 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$103,465 · 27 payments
- Consulting Fee$9,420 · 3 payments
- Travel and Lodging$7,747 · 33 payments
- Food and Beverage$3,750 · 52 payments
- Education$32.27 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Interventional Cardiology providers in Washington
- 1164737490
- 1750317533
- 1194982892
- 1508995150
All Internal Medicine, Interventional Cardiology providers in Missouri →